Pura Vida Investments’s TG Therapeutics TGTX Stock Holding History

Pura Vida Investments’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-504,829	Closed	-$5.97M	–	167
2022 Q4	$5.97M	Sell	504,829 -695,984	-58%	-$5.05M	0.31%	79
2022 Q3	$7.11M	Buy	1,200,813 +250,000	+26%	+$1.64M	0.41%	64
2022 Q2	$4.04M	Buy	950,813 +622,626	+190%	+$3.89M	0.23%	100
2022 Q1	$3.12M	Buy	+328,187	New	+$3.8M	0.1%	141
2021 Q1	–	Sell	-23,029	Closed	-$1.2M	–	258
2020 Q4	$1.2M	Buy	+23,029	New	+$778K	0.04%	160
2020 Q3	–	Sell	-141,364	Closed	-$2.75M	–	175
2020 Q2	$2.75M	Sell	141,364 -37,600	-21%	-$606K	0.26%	81
2020 Q1	$1.76M	Sell	178,964 -98,675	-36%	-$1.25M	0.21%	69
2019 Q4	$3.08M	Sell	277,639 -77,080	-22%	-$586K	0.27%	73
2019 Q3	$1.99M	Hold	354,719	–	–	0.34%	67
2019 Q2	$3.07M	Buy	354,719 +290,000	+448%	+$2.19M	0.47%	66
2019 Q1	$520K	Buy	+64,719	New	+$350K	0.07%	96
2018 Q3	–	Sell	-50,000	Closed	-$658K	–	127
2018 Q2	$658K	Hold	50,000	–	–	0.26%	79
2018 Q1	$710K	Buy	+50,000	New	+$639K	0.42%	54

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pura Vida Investments's TGTX Position: Q1 2023 in Review

Pura Vida Investments sold out of TG Therapeutics (TGTX) in Q1 2023, closing a stake of 504,829 shares — an estimated $5.97M sold.

Pura Vida Investments first reported a position in TGTX in Q1 2018 and held it in 13 quarters. The position peaked at $7.11M in Q3 2022. 214 funds tracked by Wall St. Rank hold TGTX as of Q1 2023.

Pura Vida Investments reported no remaining TG Therapeutics position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 504,829 TG Therapeutics shares in Q1 2023, an estimated $5.97M.
Pura Vida Investments first reported a position in TG Therapeutics in Q1 2018 and held it in 13 quarters.
Pura Vida Investments's TG Therapeutics position peaked at $7.11M in Q3 2022.
214 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.